This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Wed Jun 19, 2013 11:55 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 2 posts ] 
Author Message
PostPosted: Thu Feb 10, 2005 3:11 am 
Offline
Family Elder
User avatar

Joined: Sat Sep 25, 2004 3:00 pm
Posts: 240
Location: Bristol, England
Whilst MS is not specifically mentioned in this release the fact that Serono are involved makes it very likely

Quote:
19 January 2005 Vernalis Plc: Anti-Inflammatory Compound Partnered with Serono Starts Clinical Trials Vernalis plc (LSE:VER, Nasdaq: VNLS), today announced that its partner Serono (virt-x: SEO and NYSE: SRA) has started a phase I clinical trial of a selective inhibitor of MMP-12 (matrix metalloprotease inhibitor-12). This is the first compound to enter the clinic resulting from the research collaboration between Vernalis and Serono that was established to find potential treatments for inflammatory diseases. Under the terms of the agreement Vernalis will receive an undisclosed milestone payment.

The phase I trial will be performed in healthy volunteers. Its primary objectives are to elucidate the safety, tolerability and pharmacokinetic properties of the compound. Serono will conduct and fund all development activities associated with the programme.

Simon Sturge, chief executive officer of Vernalis said, "We are delighted that our partner Serono has progressed this compound into phase I trials, which endorses Vernalis' scientific expertise and further expands the Company's portfolio of products in the clinic."


Interestingly enough in the 'grey matter' thread we came to the conclusion that targeting the MMPs was a potential treatment stategy.

Maybe we aint so dumb after all... :wink:

_________________
Do not go gentle into that good night. Rage, rage against the dying of the light.


Top
 Profile  
 
 Post subject:
PostPosted: Thu Feb 10, 2005 6:22 pm 
Offline
Family Elder
User avatar

Joined: Wed Aug 11, 2004 3:00 pm
Posts: 1610
A little info on a related research grant from the Canadian MS Society...


Voon Wee Yong, PhD
University of Calgary

Matrix metalloproteinases in process extension and myelin formation by oligodendrocytes

$304,703 (April 1/01 - March 31/04)

The formation of the myelin sheath that surrounds nerves of the CNS depends on the production of long, slender membranes that radiate from oligodendrocytes, the myelin-producing cells. Stopping the myelin loss that results in MS could involve ways to enhance the first step of myelin formation -- the extension of membranes from the oligodendrocytes.

Dr. Yong and his team are continuing to study a group of enzymes, called matrix metalloproteinases (MMPs), that they have shown are active in oligodendrocytes. One in particular, MMP-9, may be involved in the process used by oligodendrocytes to extend their membranes. Their studies on adult mouse brain have shown that although MMP-9 is critical for early process extension, it is not solely responsible for it. In fact, they discovered that MMP-12 may be even more important than MMP-9 during the myelination process. In future work, the investigators will continue to probe the role of MMP-9 and MMP-12 in myelination.

The process of membrane extension is pivotal for the normal development and function of nerves. This work may lead to new therapies based on MMPs which would promote remyelination in people with MS.

http://www.mssociety.ca/en/research/pro ... .htm#antel


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 2 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Phase I for cathepsin S inhibitor CRA-028129

dignan

2

1639

Wed Jun 21, 2006 10:08 am

dignan View the latest post

There are no new unread posts for this topic. Antisense VLA-4 inhibitor starts Phase II trials

dignan

0

1592

Tue Dec 21, 2004 10:28 am

dignan View the latest post

There are no new unread posts for this topic. New Phase 1 trial

dignan

2

1842

Fri Jul 29, 2005 8:25 am

dignan View the latest post

There are no new unread posts for this topic. A new phase II trial starting

dignan

0

1332

Mon Jul 11, 2005 7:30 am

dignan View the latest post

There are no new unread posts for this topic. Article about MN-166 Phase II trial

dignan

0

1351

Fri Sep 02, 2005 10:37 am

dignan View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum